NCT03701568View on ClinicalTrials.gov

A RETROspective Study of Patients With TK2d

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

April 30, 2019

Study Completion Date

May 31, 2019

Conditions
Thymidine Kinase 2 (TK2)
Interventions
DRUG

dC/dT

Collection of retrospective data from TK2 patients previously treated with dC/dT

Trial Locations (8)

10032

Columbia University Medical Center, New York

28041

Hospital 12 de Octubre, Madrid

41013

Hospital Universitario Virgen del Rocio, Seville

3109601

Rambam Hospital, Haifa

5822012

Wolfson Medical Center, Holon

89 כביש

Western Galilee Hospital, Nahariya

08035

Hospital Vall d'Hebron, Barcelona

08950

Sant Joan de Déu Hospital, Barcelona

All Listed Sponsors
lead

Zogenix MDS, Inc.

INDUSTRY

NCT03701568 - A RETROspective Study of Patients With TK2d | Biotech Hunter | Biotech Hunter